Statutory Instruments

2008 No. 1284

Consumer Protection

The Cosmetic Products (Safety) Regulations 2008

Made

13th May 2008

Laid before Parliament

13th May 2008

Coming into force

18th June 2008

Go to Explanatory Note

The Secretary of State is a Minister designated for the purposes of section 2 of, and paragraph 1A of Schedule 2 to, the European Communities Act 1972(1) in relation to measures for safety and consumer protection as respects cosmetic products and any provisions concerning the composition, labelling, marketing, classification or description of cosmetic products and in relation to indication of origin on imported goods(2).

These Regulations make provision for a purpose mentioned in section 2(2) of the European Communities Act 1972 and it appears to the Secretary of State that it is expedient for certain references to provisions of Community instruments to be construed as references to those provisions as amended from time to time.

In accordance with section 11(5) of the Consumer Protection Act 1987 the Secretary of State has consulted such organisations as appear to him to be representative of interests substantially affected by the following Regulations, such other persons as he considered appropriate and the Health and Safety Commission.

The Secretary of State makes regulations 10, 11, 14, 16(1)(i) and regulation 26 in exercise of the powers conferred by section 2(2) of the European Communities Act 1972 (as read with paragraph 1A of Schedule 2 to that Act and all other provisions in these Regulations in exercise of the powers conferred by section 11 of the Consumer Protection Act 1987(3).

Citation, Commencement and revocation

1.—(1) These Regulations may be cited as the Cosmetic Products (Safety) Regulations 2008 and shall come into force on 18th June 2008.

(2) The Regulations listed in Schedule 1 are revoked.

Transitional provisions

2.—(1) In Schedule 4 (substances subject to restrictions and conditions) the labelling requirement for any toothpaste containing 0.1 to 0.15% fluoride in respect of entries numbered 26 to 43, 47 and 56 of Part 1 does not apply until 19th March 2009.

(2) In Schedule 5 (colouring agents) the substance numbered 45425 is omitted after 17th October 2008.

(3) In Schedule 6 (Preservatives) reference number 10 is deleted and the text of entry 56 is replaced after 17th October 2008.

(4) Cosmetic products which fail to comply with the amendments to these Regulations referred to in paragraphs (2) and (3) may not be placed on the market by EEA manufacturers or by importers established within the EEA after 17th October 2008 and cosmetic products which fail to comply with those changes may not be disposed of to the final consumer after 18th April 2009.

Interpretation

3.  In these Regulations—

“the 1987 Act” means the Consumer Protection Act 1987;

“agent” means an agent established within the EEA appointed by a manufacturer of a cosmetic product to act on his behalf in relation to these Regulations;

“cosmetic ingredient” means any chemical substance or preparation of synthetic or natural origin, except for perfume and aromatic compositions, used in the composition of a cosmetic product;

“cosmetic product” means any substance or preparation intended to be placed in contact with the various external parts of the human body (epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, correcting body odours, protecting them, or keeping them in good condition except where such cleaning, perfuming, protecting, changing, keeping or correcting is wholly for the purpose of treating or preventing disease;

“cosmetic product intended to come into contact with the mucous membranes” means a cosmetic product intended to be applied in the vicinity of the eyes, on the lips, in the oral cavity or to the external genital organs, and does not include any cosmetic product which is intended to come into only brief contact with the skin;

“the Directive” means Council Directive 76/768/EEC(4) as amended by the Community instruments set out in Schedule 2;

“the EEA” means the area comprised of the EEA States;

“finished cosmetic product” means the cosmetic product in its final formulation as placed on the market and made available to the final consumer, or its prototype;

“Member State” means an EEA State;

“preservative” means a substance which is added to a cosmetic product for the primary purpose of inhibiting the development of micro-organisms in that product;

“prototype” means a first model or design that has not been produced in batches and from which the finished cosmetic product is copied or finally developed;

“supply” includes offering to supply, agreeing to supply, exposing for supply and possessing for supply, and cognate expressions shall be construed accordingly; and

“UV filter” means a substance which is added to a sunscreen cosmetic product for the primary purpose of filtering ultra violet rays for the purpose of protecting the epidermis of the user from harmful effects of such ultra violet rays.

General safety requirement

4.—(1) No person shall supply a cosmetic product which may cause damage to human health when applied under normal or reasonably foreseeable conditions of use, taking into account, in particular—

(a) the product’s presentation,

(b) its labelling,

(c) any instructions for its use and disposal, and

(d) any other indications or information provided by the manufacturer or his authorised agent or by any other person responsible for placing the product on the market in the EEA.

(2) Paragraph (1) only applies to the supply by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, to the supply by that other person.

(3) The provision of warnings shall not, in any event, exempt any person from compliance with the other requirements of these Regulations.

Substances prohibited in cosmetic products

5.—(1) No person shall supply a cosmetic product containing a substance listed in Schedule 3 (substances which must not form part of the composition of cosmetic products).

(2) The presence of traces of a substance listed in Schedule 3 is allowed provided that such presence is technically unavoidable in good manufacturing practice.

Substances subject to restrictions and conditions

6.  No person shall supply a cosmetic product containing a substance listed in Part 1 (substances subject to restrictions and conditions) or Part 2 (substances subject to restrictions and conditions provisionally allowed) of Schedule 4 unless the restrictions and conditions there set out in respect of that substance are satisfied.

Colouring agents

7.—(1) No person shall supply a cosmetic product containing a colouring agent—

(a) that is not listed in Schedule 5,

(b) that is listed in Schedule 5 unless the restrictions and conditions there set out in respect of that substance are satisfied.

(2) Paragraph (1) does not apply to a cosmetic product containing a colouring agent intended solely to colour hair.

Preservatives

8.  No person shall supply a cosmetic product containing a preservative—

(a) that is not listed in Schedule 6,

(b) that is listed in Schedule 6 unless the requirements set out in columns (c) (d) and (e) of Schedule 6 are satisfied,

(c) beyond the limits and outside the conditions laid down in Schedule 6 except where other concentrations are used for specific purposes apparent from the presentation of the product;

UV Filters

9.  No person shall supply a cosmetic product containing a UV filter—

(a) that is not listed in Schedule 7,

(b) that is listed in Schedule 7, unless the requirements in columns (c), (d) and (e) of that Schedule are satisfied.

Restrictions on animal testing

10.—(1) No person shall supply a cosmetic product where, in order that the cosmetic product, or an ingredient or combination of ingredients might meet a requirement of these Regulations or the Directive—

(a) the final formulation, or

(b) an ingredient or combination of ingredients contained in the cosmetic product

has been tested on an animal using a method other than an alternative method.

(2) No person shall test any ingredient or combination of ingredients on an animal in order to meet a requirement of these Regulations or the Directive using a method other than an alternative method.

(3) Paragraph (1) applies only—

(a) where an alternative method is listed—

(i) in the Commission Regulation on test methods as specified in Article 13(2) of Regulation (EC) No. 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals(5);

(ii) in Annex IX to the Directive;

(b) after 11th March 2013 in respect of tests concerning repeated dose toxicity, reproductive toxicity and toxicokinetics;

(c) after 11th March 2009 in respect of all other tests.

(4) Paragraph (2) applies only—

(a) where an alternative method is listed—

(i) in the Commission Regulations on test methods as specified in Article 13(2) of Regulation (EC) No. 1907/2006;

(ii) in Annex IX to the Directive;

(b) after 11th March 2009 in respect of all other tests.

(5) References in paragraphs (3) and (4) to the Commission Regulation on test methods and to Annex IX to the Directive are to that Regulation and Annex as amended from time to time.

11.  No person shall test a finished cosmetic product on an animal where such testing is undertaken in order that the product might satisfy a requirement of these Regulations or the Directive.

Labelling requirements

12.—(1) No person shall supply a cosmetic product unless the container and packaging displays the following information in indelible, easily legible and visible lettering—

(a) the name or style and the address or registered office of the manufacturer or the person responsible for marketing the cosmetic product who is established within the EEA. Such information may be abbreviated in so far as the abbreviation makes it generally possible to identify the undertaking. Where the cosmetic product is manufactured outside the EEA, the country of origin must also be specified.

(b) the date of minimum durability—

(i) indicated by the words: ‘best used before the end of’ followed by either the date itself, or details of where it appears on the packaging;

(ii) clearly expressed and consisting of either the month and year or the day, month and year in that order;

(iii) supplemented, if necessary, by an indication of the conditions which must be satisfied to guarantee the stated durability;

except where the cosmetic product has a minimum durability of more than 30 months, in which case it is not mandatory to indicate the date of durability, but such a product shall have an indication of the period of time after opening for which the product can be used without any harm to the consumer. This information shall be indicated by the symbol given in Part 2 of Schedule 8 followed by the period in months or years or both months and years.

(c) particular precautions to be observed in use. The ‘Conditions of use and warnings which must be printed on the label’ set out in Schedules 4, 5, 6 and 7 and any special precautionary information on cosmetic products for professional use, in particular in hairdressing, must appear on the container and packaging;

(d) the batch number of manufacture or the reference for identifying the goods;

(e) the function of the product, unless it is clear from the presentation of the product.

(2) No person shall supply a cosmetic product unless the packaging in which it is supplied bears, in indelible, easily legible and visible lettering a list, preceded by the word ‘ingredients’ of the ingredients in descending order of weight as they are added—

(a) an ingredient must be identified by the name provided for in the International Nomenclature of Cosmetic Ingredients (INCI) or in the absence of such identification, by its chemical name, its European Pharmacopoeia name, its International Non-proprietary name (INN) as recommended by the World Health Organisation, its EINECS, ELINCS or CAS identification reference or its colour index number(6).

(b) the following shall not however be regarded as ingredients:

(i) impurities in the raw materials used;

(ii) subsidiary technical materials used in the preparation but not present in the final product;

(iii) materials used in strictly necessary quantities as solvents or as carriers for perfumes and aromatic compositions;

(c) perfume and aromatic compositions and their raw materials shall be referred to by the word ‘perfume’ or ‘aroma’.

(d) the presence of substances, the mention of which is required under the column ‘other limitations and requirements’ in Schedule 4 shall be indicated in the list irrespective of their function in the product;

(e) ingredients in concentrations of less than 1% may be listed in any order after those in concentrations of more than 1%;

(f) colouring agents may be listed in any order after the other ingredients, in accordance with the colour index number or denomination adopted in Schedule 5;

(g) for decorative cosmetic products marked in several colour shades, all colouring agents used in the range may be listed, provided that the words ‘may contain’ or ‘+/-‘ are added.

(3) The particulars referred to—

(a) in paragraph 1(b), (c) and (e) above shall be in English, but this shall not prohibit the additional use of other languages;

(b) in paragraph (2) shall be in a language easily understood by the consumer.

(4) Where two or more cosmetic products are supplied together as a single item, each product being in a separate container and the containers being enclosed together in packaging which bears clear and conspicuous instructions to the effect that the products must be mixed together in specified proportions before use, the particulars referred to in paragraph (1)(c) shall appear on an enclosed leaflet and an indication shall appear on both the containers and the packaging referring the consumer to the information in the leaflet.

13.—(1) Where a cosmetic product other than soap is supplied in neither a container nor packaging, the particulars referred to in paragraph (1) shall appear on the container in which the product is exposed for supply or a notice in immediate proximity to that container.

(2) Where a cosmetic product has no packaging or it is impossible for practical reasons for the list of ingredients referred to in regulation 12(2) to appear on the packaging, the list shall appear on the container; and where a cosmetic product is supplied in neither a container nor packaging, the list shall appear on the container in which the product is exposed for supply or a notice in immediate proximity.

(3) Where it is impossible for practical reasons for the required particulars as to the conditions of use or list of ingredients to appear on the container and packaging an enclosed leaflet, label, tape or card must contain that information to which the consumer is referred either by abbreviated information or the symbol in Part 1 of Schedule 8 which—

(a) in the case of conditions of use must appear on the container and the packaging, and

(b) in the case of the list of ingredients, must appear on the packaging.

(4) Where it is impracticable, for reasons of size or shape, for the required particulars as to the conditions of use or list of ingredients to appear in an enclosed leaflet those particulars shall appear on a label, tag, tape or card which is enclosed or attached to the cosmetic product.

(5) In the case of soap, bath balls and other small products where it is impracticable, for reasons of size or shape, for the required information as to the ingredients to appear on a label, tag, tape or card or in an enclosed leaflet, those particulars shall appear on a notice in immediate proximity to the container in which the cosmetic product is exposed for sale.

(6) Where it is impossible for practical reasons for the batch number of manufacturer or the reference for identifying the goods to appear on the container and packaging because the cosmetic product is too small such information need only appear on the packaging.

14.  The supply of a cosmetic product in respect of which a claim that the product or its ingredients have not been tested on animals appears on the product packaging or in any documents, notice, label, ring or collar accompanying or referring to the product is only permitted if—

(a) the manufacturer and his supplier have not carried out any such tests on the finished product, its prototype or on any of the ingredients contained in the finished product or its prototype;

(b) the manufacturer and his supplier have not commissioned any such tests on the finished product, its prototype or on any of the ingredients contained in the finished product or its prototype; and

(c) the cosmetic product contains no ingredients which have been tested on animals by others for the purposes of developing new cosmetic products.

Responsible persons and competent authorities

15.—(1) A responsible person means in relation to a relevant cosmetic product—

(a) the manufacturer of the product,

(b) the manufacturer’s agent,

(c) the person to whose order that cosmetic product is manufactured, or

(d) where the manufacturer or the person to whose order the cosmetic product is manufactured is not established in the EEA and either—

(i) the manufacturer has not appointed an agent, or

(ii) the manufacturer’s agent is not the supplier of that cosmetic product,

the person who first supplies the cosmetic product in the EEA.

(2) A “competent authority” means a body responsible for requiring and receiving the information provided for in regulations 16, 17 and 19 and granting and refusing requests for confidentiality in accordance with regulation 21, and which is—

(a) a United Kingdom competent authority; or

(b) a competent authority of a Member State other than the United Kingdom, having been notified as a competent authority by the Member State concerned to the Commission in accordance with Articles 7.3 and 7a.5 of the Directive and Article 10 of Directive 95/17/EC(7);

(3) The United Kingdom competent authority shall be the Secretary of State provided that he may from time to time appoint such person as he thinks fit to be a United Kingdom competent authority in addition to or in substitution for himself.

Information to be made accessible to competent authority

16.—(1) Where a cosmetic product is manufactured or supplied in the United Kingdom a responsible person shall keep the following information easily accessible to a United Kingdom competent authority for control purposes—

(a) the qualitative and quantitative composition of the product, except to the extent that the product is composed of any perfume or perfume composition, in which case the responsible person shall only be required to keep the name and code number of the perfume or perfume composition and the identity of the supplier;

(b) the physico-chemical and microbiological specifications of the raw materials and the finished product and the purity and microbiological control criteria of the cosmetic product;

(c) the method of manufacture which shall be in accordance with good manufacturing practice, that is to say that the cosmetic product shall be manufactured in such a way that under normal and reasonably foreseeable conditions of use it shall not endanger human health or safety;

(d) a health assessment;

(e) a specific health assessment in respect of cosmetic products intended for use on children under the age of 3 and for cosmetic products intended exclusively for use in external intimate hygiene;

(f) the name and address of the qualified person or persons responsible for the health assessment;

(g) existing data on undesirable effects on human health resulting from use of the cosmetic product;

(h) proof of the effect claimed for the cosmetic product, where justified by the nature of the effect or product; and

(i) data on any animal testing performed by the manufacturer, his agents or suppliers, relating to the development or safety evaluation of the product or its ingredients, including any animal testing performed to meet the legislative or regulatory requirements of countries which are not Member States;

the information should be kept available at the address or registered office specified on the container or packaging of the cosmetic product.

(2) In this regulation, “health assessment” means an assessment of the safety for human health of the finished product. The health assessment shall be carried out in accordance with the principles of good laboratory practice referred to in Article 1 of European Parliament and Council Directive 2004/10/EC(8) on the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances and shall take particular account of the following—

(a) the general toxicological profile of each ingredient used;

(b) the chemical structure of each ingredient;

(c) the level of exposure of each ingredient;

(d) the specific exposure characteristics of the areas on which the cosmetic product will be applied; and

(e) the specific exposure characteristics of the class of individuals for whom the cosmetic product is intended.

(3) Without prejudice to the protection in particular of commercial secrecy and of intellectual property rights where a cosmetic product is manufactured or supplied in the United Kingdom a responsible person shall ensure that the information specified in paragraphs (1)(a) and (1)(g) shall be made easily accessible to the public by any appropriate means.

(4) For the purposes of paragraph (3), the quantitative information required under paragraph (1)(a) shall be limited to information relating to dangerous substances covered by Directive 67/548/EEC.

(5) Where the manufacturer manufactures a cosmetic product at two or more places within the EEA, and one of those places is within the United Kingdom, the responsible person may choose a single place of manufacture within the EEA where the information referred to in paragraph (1) will be kept available provided that, if requested by a United Kingdom competent authority, the responsible person informs the said authority of the location at which the said information is to be kept.

(6) Where the information referred to in paragraph (1) is to be kept accessible to a United Kingdom competent authority it must be in English or a language readily understood by the said authority.

17.  Where the place of manufacture or initial importation into the EEA of a type of cosmetic product is within the United Kingdom, the responsible person shall notify a United Kingdom competent authority of the address of the place of manufacture or, as the case may be, initial importation into the EEA of that type of cosmetic product before its first supply in the EEA.

Qualified persons

18.—(1) The qualified person referred to in regulation 16(1)(f) must be—

(a) a person who is “appropriately qualified” within the meaning of article 11(1)(a)(i) of the Pharmacists and Pharmacy Technicians Order 2007(9) or any other person who has the right, granted by a competent authority of a Member State, to take up and pursue the activities of a pharmacist;

(b) a person who is entitled to be registered under section 3(1) of the Medical Act 1983(10) as a fully registered medical practitioner and who has the right, granted by a competent authority in a Member State, to take up and pursue the activities of a doctor; or

(c) the holder of a professional qualification within the meaning of regulation 7 of the European Communities (Recognition of Professional Qualifications) Regulations 2007(11) showing that the holder has the qualifications required to practise as a chartered biologist or as a chartered chemist or a profession equivalent to the profession of chartered biologist or chartered chemist in a Member State other than the United Kingdom.

(2) Any diploma or other evidence of qualification required for the purposes of paragraph (1)(a) or (b) shall satisfy that requirement only if—

(a) the education and training attested were received mainly within the EEA; or

(b) the holder has spent at least three years in lawful pursuit in a Member State of the relevant profession, and such professional experience has been certified by a competent authority in a Member State (being a State which recognised a diploma or other evidence of qualification obtained in a non-Member State).

Medical treatment

19.—(1) A United Kingdom competent authority may, where difficulties are encountered in providing prompt and appropriate medical treatment, require any holder of appropriate and adequate information on substances used in cosmetic products to make such information available to it, where the difficulties referred to may be overcome or eased by the provision of the said information.

(2) Where the information referred to in paragraph (1) is made available, the United Kingdom competent authority shall ensure that it is used solely for the purposes of the treatment referred to in paragraph (1).

Authorisation by the Secretary of State

20.—(1) The Secretary of State may authorise the use in a cosmetic product for a maximum period of three years of a particular substance, not being a substance or ingredient listed in Schedule 3 (substances which must not form part of the composition of cosmetic products) or Schedule 4 (substances subject to restrictions and conditions).

(2) An authorisation as to the use of a particular substance in a cosmetic product may contain conditions relating to any matter which the Secretary of State considers appropriate including—

(a) the purpose of the substance,

(b) the type of cosmetic product,

(c) the maximum concentration of the substance in any cosmetic product, and

(d) information and labelling requirements.

(3) The Secretary of State may on reasonable notice vary or revoke any authorisation given under paragraph (1).

(4) The Secretary of State shall arrange for the authorisation, variation or revocation, as the case may be, to be published in such manner as he considers appropriate for bringing it to the attention of persons who, in his opinion, would be likely to have an interest in it.

(5) The fact that a cosmetic product contains a particular substance does not constitute a contravention of these Regulations provided that at the relevant time—

(a) the use of that particular substance in that cosmetic product was duly authorised; and

(b) all of the conditions imposed by the authorisation were complied with.

Requests for confidentiality

21.—(1) A responsible person who for reasons of trade secrecy wishes not to include one or more cosmetic ingredients in the list of cosmetic ingredients referred to in regulation 12(2) shall submit a request to that effect to the competent authority.

(2) In this regulation “applicant” means a responsible person who submits a request for confidentiality.

(3) The applicant shall ensure that—

(a) the request for confidentiality includes the particulars laid down in Part 1 of Schedule 9; and

(b) any amendments to the particulars provided for in sub-paragraph (a) are communicated as quickly as possible to the competent authority and, in particular, that all changes to the names of cosmetic products containing the cosmetic ingredient in respect of which confidentiality is or has been sought, are communicated to the competent authority at least 15 days before those cosmetic products are supplied under their new names.

(4) Within four months of the receipt of a request for confidentiality in respect of which the requirements of paragraph (3)(a) are satisfied, the competent authority shall examine the request and inform the applicant in writing of its decision.

(5) If the competent authority decides to grant its approval to the applicant’s request it shall, in notifying the applicant of its decision, in accordance with paragraph (4), also notify the applicant of the registration number which will replace the cosmetic ingredient in question in the list referred to in regulation 12(2), the said number to be allocated to the product in accordance with the procedure provided for in Part 2 of Schedule 9.

(6) If the competent authority refuses to grant its approval to the applicant’s request it shall, in its notification of this refusal, include a statement of the reasons for refusal and a clear explanation of appeals procedures and their time limits.

(7) In exceptional cases the competent authority may inform the applicant in writing that a period of two months in addition to the four-month period referred to in paragraph (4) is required for the examination of the request.

(8) A decision granting confidentiality shall be valid for a period of five years.

(9) An applicant may, by submitting a reasoned request to the competent authority, request that the period of confidentiality referred to in paragraph (8) be extended.

(10) In the event of a reasoned request being submitted in accordance with paragraph (9), the competent authority shall deal with the request in accordance with paragraphs (4), (5) and (6).

(11) Any extension of the period of confidentiality shall not exceed three years.

(12) The competent authority may withdraw its approval to an applicant’s request for confidentiality if it considers this appropriate taking into account—

(a) any amendments to the particulars provided for in paragraph (3)(a) which are communicated to it in accordance with paragraph (3)(b); and

(b) any new information which comes to its attention which makes it imperative, particularly for compelling reasons of public health, for it to so act,

and in withdrawing its approval the competent authority shall comply with the provisions of paragraphs (4), (6) and (7).

Contravention of these Regulations

22.—(1) For the purposes of the 1987 Act—

(a) these regulations, with the exception of regulations 10, 11, 14 and 16(1)(i) are safety regulations made under section 11 of the 1987 Act;

(b) regulations 10,11,14 and 16(1)(i), which are not made under the 1987 Act, shall be treated as if they were safety regulations made for all purposes under section 11 of the 1987 Act.

(2) The term of imprisonment to which a person guilty of an offence of contravening a requirement of regulations 16, 17 or 19 shall be liable on summary conviction shall not exceed three months.

(3) Any person guilty of an offence under paragraph (1)(b) shall be liable, on summary conviction, to a fine not exceeding the statutory maximum or to imprisonment not exceeding three months and, on conviction on indictment, to a fine or to imprisonment not exceeding six months.

Enforcement

23.—(1) No proceedings shall be brought and no enforcement action taken in respect of—

(a) a failure to comply with regulations 4 to 9, 12, 13, 16, 17 and 18 where the cosmetic product is supplied for the purposes of exporting that product to any country which is not a Member State; or

(b) a failure to comply with regulation 12(3)(a) in any case in which the enforcement authority is satisfied that the person supplying the cosmetic product reasonably believes that it will not be used in the United Kingdom.

(2) For the purposes of this regulation, “enforcement action” means action taken pursuant to or in connection with sections 13, 14, 16, 17, 28, 29, 30 or 31 of the 1987 Act.

24.  Any test of goods purchased under section 28 or seized under section 29 of the 1987 Act (which relate to enforcement) by or on behalf of an enforcement authority for the purpose of ascertaining whether the provisions of these Regulations have been contravened shall in all cases be carried out in accordance with the provisions of paragraphs 2 to 5 of Schedule 10 and any test for which a method is specified in paragraph 6 of Schedule 10 shall be carried out in accordance with that method.

Proceedings

25.  No proceedings for an offence under these Regulations shall be commenced after the earlier of—

(a) the end of the period of three years beginning with the date of the commission of the offence, or

(b) the end of the period of one year beginning with the date of the discovery of the offence by the prosecutor.

Amendment to Legislative and Regulatory Reform (Regulatory Functions) Order 2007

26.—(1) In the Schedule to the Legislative and Regulatory Reform (Regulatory Functions) Order 2007(12), Part 3 is amended as follows.

(2) In the heading “Consumer and business protection”, after the entry for the Consumer Protection from Unfair Trading Regulations 2008, insert “Cosmetic Products (Safety) Regulations 2008”.

Gareth Thomas

Parliamentary Under-Secretary of State for Trade and Consumer Affairs

Department for Business, Enterprise & Regulatory Reform

13th May 2008

Regulation 1(2)

SCHEDULE 1 Regulations revoked

Regulation revoked Reference:
The Cosmetic Products (Safety) Regulations 2004 S.I. 2004/2152
The Cosmetic Products (Safety) (Amendment) Regulations 2004 S.I. 2004/2361
The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2004 S.I. 2004/2988
The Cosmetic Products (Safety) (Amendment) Regulations 2005 S.I. 2005/1815
The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2005 S.I. 2005/3346
The Cosmetic Products (Safety) (Amendment) Regulations 2006 S.I. 2006/1198
The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2006 S.I. 2006/2231
The Cosmetic Products (Safety) (Amendment) (No. 3) Regulations 2006 S.I. 2006/2907
The Cosmetic Products (Safety) (Amendment) Regulations 2007 S.I. 2007/1623
The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2007 S.I. 2007/2400
The Cosmetic Products (Safety) (Amendment) (No. 3) Regulations 2007 S.I. 2007/3452

Regulation 3

SCHEDULE 2 LIST OF DIRECTIVES IMPLEMENTED BY THESE REGULATIONS

1.  Council Directive 82/368/EEC (O.J. No. L167, 15.6.82, p.1).

2.  Commission Directive 82/147/EEC (O.J. No. L63, 6.3.82, p.26).

3.  Commission Directive 83/191/EEC (O.J. No. L109, 26.4.83, p.25).

4.  Commission Directive 83/341/EEC (O.J. No. L188, 13.7.83, p.15).

5.  Council Directive 83/574/EEC (O.J. No. L332, 28.11.83, p.38).

6.  Commission Directive 83/496/EEC (O.J. L275, 8.10.83, p.20).

7.  Commission Directive 84/415/EEC (O.J. No. L228, 25.8.84, p.31).

8.  Commission Directive 85/391/EEC (O.J. L224, 22.8.85, p.40).

9.  Commission Directive 86/179/EEC (O.J. No. L138, 24.5.86, p.40).

10.  Commission Directive 86/199/EEC (O.J. No. L149, 3.6.86, p.38).

11.  Commission Directive 87/137/EEC (O.J. No. L56, 26.2.87, p.20).

12.  Commission Directive 88/233/EEC (O.J. L105, 26.4.88, p.11).

13.  Council Directive 88/667/EEC (O.J. No. L382, 31.12.88, p.46).

14.  Commission Directive 89/174/EEC (O.J. No, L64, 8.3.89, p.10).

15.  Directive 89/679/EEC (O.J. No. L398, 30.12.89, p.25).

16.  Commission Directive 90/12/EEC (O.J. No. L71, 17.3.90, p.40).

17.  Commission Directive 91/184/EEC (O.J. No. L91, 12.4.91, p.59).

18.  Commission Directive 92/8/EEC (O.J. No. L70, 17.3.92, p.23).

19.  Commission Directive 92/86/EEC (O.J. No.L325, 11.11.92, p.18).

20.  Commission Directive 93/47/EEC (O.J. No. L203, 13.8.93, p.24).

21.  Council Directive 93/35/EEC (O.J. No. L151, 23.6.93, p.32).

22.  Commission Directive 94/32/EC (O.J. No. L181, 15.7.94, p.31).

23.  Commission Directive 95/34/EC (O.J. No. L167, 18,7.95, p.19).

24.  Commission Directive 96/41/EC (OJ No. L198, 8.8.96, p.36).

25.  Commission Directive 97/18/EC (O.J. No. L114, 1.5.97, p.43).

26.  Commission Directive 97/45/EC (O.J. No. L196, 24.7.97, p.77).

27.  Commission Directive 98/16/EC (O.J. No. L77, 14.3.98, p.44).

28.  Commission Directive 98/62/EC (O.J. No. L253, 15.9.98, p.20).

29.  Commission Directive 2000/6/EC (O.J. No. L56, 1.3.00, p.42).

30.  Commission Directive 2000/11/EC (O.J. No. L65, 14.3.00, p.22).

31.  Commission Directive 2000/41/EC (O.J. No. L145, 20.6.00, p.25).

32.  Commission Directive 2002/34/EC (O.J. No. L102, 18.4.02, p.19).

33.  Commission Directive 2003/1/EC (O.J. No. L5, 10.1.03, p.14).

34.  Commission Directive 2003/16/EC (O.J. No. L46, 20.2.03, p.24).

35.  Commission Directive 2003/15/EC (O.J. No. L66, 11.3.03, p.26).

36.  Commission Directive 2003/80/EC (O.J. No. L238, 25.9.03, p.23).

37.  Commission Directive 2003/83/EC (O.J. No. L238, 25.9.03, p.23).

38.  Commission Directive 2004/87/EC (O.J. No. L287, 8.9.2004, p.4).

39.  Commission Directive 2004/88/EC (O.J. No. L287, 8.9.2004, p.5).

40.  Commission Directive 2004/94/EC (O.J. No. L24, 7.9.2000 p.28).

41.  Commission Directive 2004/93/EC (O.J. No. L300, 25.9.2004, p.13).

42.  Commission Directive 2005/9/EC (O.J. No. L27, 29.1.2005, p.46).

43.  Commission Directive 2005/42/EC (O.J. No. L158, 21.6.2005, p.17).

44.  Commission Directive 2005/52/EC (O.J. No, L234, 10.9.2005, p.9).

45.  Commission Directive 2005/80/EC (O.J. No. L303, 22.11.2005, p.32).

46.  Commission Directive 2006/65/EC (O.J. No. L198, 20.7.2006, p.11).

47.  Commission Directive 2006/78/EC (O.J. No. L271, 30.9.2006, p.56).

48.  Commission Directive 2007/1/EC (O.J. No. L25, 1.2.2007, p.9).

49.  Commission Directive 2007/17/EC (O.J. No.L82, 23.3.2007, p.27).

50.  Commission Directive 2007/22/EC (O.J. No. L101, 18.4.2007, p.11).

51.  Commission Directive 2007/53/EC (O.J. No. L226, 30.8.2007, p.19).

52.  Commission Directive 2007/54/EC (O.J. No. L226, 30.8.2007, p.21).

53.  Commission Directive 2007/67/EC (O.J. No. L305, 23.11.2007, p.22).

Regulations 5(1) and 20(1)

SCHEDULE 3 LIST OF SUBSTANCES WHICH MUST NOT FORM PART OF THE COMPOSITION OF COSMETIC PRODUCTS (UNLESS OTHERWISE SPECIFIED)

Naming of substances is based on botanical Latin names, International Nomenclature of Cosmetic Ingredients (INCI), International Non-proprietary Names (INN) and International Organization of Standardization (ISO)

No. Name of Substance EC No CAS No.
(1)

OJ L 159, 29.6.1966, p.1.s

(2)

OJ L 147, 9.6.1975, p.13.

(3)

OJ L 273, 10.10.2002, p.1.

(4)

OJ L 147, 31.5.2001, p.1.

(5)

For the individual ingredient see reference number 364 in Schedule 3.

(6)

For the individual ingredient see reference number 413 in Schedule 3.

1 N-5-(Chlorobenzoxazol-2-yl) acetamide 35783-57-4
2 2-Acetoxyethyltrimethylammonium hydroxide (acetylcholine) and its salts 200-128-9 51-84-3
3 Deanol aceglumate (INN) 222-085-5 3342-61-8
4 Spironolactone (INN) 200-133-6 52-01-7
5 [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts 200-086-1 51-24-1
6 Methotrexate (INN) 200-413-8 59-05-2
7 6-Aminocaproic acid (INN) and its salts 200-469-3 60-32-2
8 Cinchophen (INN), its salts, derivatives and salts of these derivatives 205-067-1 132-60-5
9 Thyropropic acid (INN) and its salts 51-26-3
10 Trichloroacetic acid 200-927-2 76-03-9
11 Aconitum napellus L. (leaves, roots and galenical preparations) 283-252-6 84603-50-9
12 Aconitine (principal alkaloid of Aconitum napellus L.) and its salts 206-121-7 302-27-2
13 Adonis vernalis L. and its preparations 283-458-6 84649-73-0
14 Epinephrine (INN) 200-098-7 51-43-4
15 Rauwolfia serpentina alkaloids and their salts 290-234-1 90106-13-1
16 Alkyne alcohols, their esters, ethers and salts
17 Isoprenaline (INN) 231-687-7 7683-59-2
18 Allyl isothiocyanate 200-309-2 57-06-7
19 Alloclamide (INN) and its salts 5486-77-1
20 Nalorphine (INN), its salts and ethers 200-546-1 62-67-9
21 Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe 206-096-2 300-62-9
22 Aniline, its salts and its halogenated and sulphonated derivatives 200-539-3 62-53-3
23 Betoxycaine (INN) and its salts 3818-62-0
24 Zoxazolamine (INN) 200-519-4 61-80-3
25 Procainamide (INN), its salts and derivatives 200-078-8 51-06-9
26 Benzidine 202-199-1 92-87-5
27 Tuaminoheptane (INN), its isomers and salts 204-655-5 123-82-0
28 Octodrine (INN) and its salts 208-851-1 543-82-8
29 2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts 530-34-7
30 1,3-dimethylpentylamine and its salts 203-296-1 105-41-9
31 4-Aminosalicylic acid and its salts 200-613-5 65-49-6
32 Toluidines, their isomers, salts and halogenated and sulphonated derivatives 248-105-2 26915-12-8
33 Xylidines, their isomers, salts and halogenated and sulphonated derivatives 215-091-4 1300-73-8
34 Imperatorin (9-(3-methoxylbut-2-enyloxy)furo[3,2-g]chromen-7-one) 207-581-1 482-44-0
35 Ammi majus and its galenical preparations 291-072-4 90320-46-0
36 2,3-Dichloro-2-methylbutane 507-45-9
37 Substances with androgenic effect
38 Anthracene oil 266-027-7 65996-92-1
39 Antibiotics
40 Antimony and its compounds 231-146-5 7440-36-0
41 Apocynum cannabinum L. and its preparations 283-253-1 84603-51-0
42 Apomorphine R 5,6,6a, 7-tetrahydro-6-methyl-4H-dibenzo [de,g] quinoline-10,11-diol and its salts 200-360-0 58-00-4
43 Arsenic and its compounds 231-148-6 7440-38-2
44 Atropa belladonna L. and its preparations 232-365-9 8007-93-0
45 Atropine, its salts and derivatives 200-104-8 51-55-8
46 Barium salts, with the exception of barium sulphate, barium sulphide under the conditions laid down in Schedule 4, Part 1, and lakes, salts and pigments prepared from the colouring agents listed with the reference (2) in Schedule 4, Part 2 and Schedule 5, Part 2.
47 Benzene 200-753-7 71-43-2
48 Benzimidazol-2(3H)-one 210-412-4 615-16-7
49 Benzazepines and benzodiazepines 12794-10-4
50 1-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts 211-411-1 644-26-8
51 2,2,6-Trimethyl-4-piperidyl benzoate (benzamine) and its salts 500-34-5
52 Isocarboxazid (INN) 200-438-4 59-63-2
53 Bendroflumethiazide (INN) and its derivatives 200-800-1 73-48-3
54 Beryllium and its compounds 231-150-7 7440-41-7
55 Bromine, elemental 231-778-1 7726-95-6
56 Bretylium tosilate (INN) 200-516-8 61-75-6
57 Carbromal (INN) 201-046-6 77-65-6
58 Bromisoval (INN) 207-825-7 496-67-3
59 Brompheniramine (INN) and its salts 201-657-8 86-22-6
60 Benzilonium bromide (INN) 213-885-5 1050-48-2
61 Tetrylammonium bromide (INN) 200-769-4 71-91-0
62 Brucine 206-614-7 357-57-3
63 Tetracaine (INN) and its salts 202-316-6 94-24-6
64 Mofebutazone (INN) 218-641-1 2210-63-1
65 Tolbutamide (INN) 200-594-3 64-77-7
66 Carbutamide (INN) 206-424-4 339-43-5
67 Phenylbutazone (INN) 200-029-0 50-33-9
68 Cadmium and its compounds 231-152-8 7440-43-9
69 Cantharides, Cantharis vesicatoria 296-298-7 92457-17-5
70 (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride (cantharidin) 200-263-3 56-25-7
71 Phenprobamate (INN) 211-606-1 673-31-4
72 Nitroderivatives of carbazole 201-696-0 86-74-8
73 Carbon disulfide 200-843-6 75-15-0
74 Catalase 232-577-1 9001-05-2
75 Cephaeline and its salts 207-591-6 483-17-0
76 Chenopodium ambrosioides (essential oil) 289-682-0 89997-47-7
77 2,2,2-Trichloroethane-1,1-diol 206-117-5 302-17-0
78 Chlorine 231-959-5 7782-50-5
79 Chlorpropamide (INN) 202-314-5 94-20-2
80 Diphenoxylate (INN) hydrochloride 223-287-6 3810-80-8
81 4-Phenylazophenylene-1,3-diamine citrate hydrochloride (chrysoidine citrate hydrochloride) 5909-04-6
82 Chlorzoxazone (INN) 202-403-9 95-25-0
83 2-Chloro-6-methylpyrimidin-4-yldimethylamine (crimidine-ISO) 208-622-6 535-89-7
84 Chlorprothixene (INN) and its salts 204-032-8 113-59-7
85 Clofenamide (INN) 211-588-5 671-95-4
86 N,N-bis(2-chloroethyl)methylamine N-oxide and its salts 126-85-2
87 Chlormethine (INN) and its salts 200-120-5 51-75-2
88 Cyclophosphamide (INN) and its salts 6055-19-2
89 Mannomustine (INN) and its salts 209-404-3 576-68-1
90 Butanilicaine (INN) and its salts 3785-21-5
91 Chlormezanone (INN) 201-307-4 80-77-3
92 Triparanol (INN) 201-115-0 78-41-1
93 2-[2(4-Chiorophenyl)-2-phenylacetyl] indane-1,3-dione (chlorophacinone-ISO) 223-003-0 3691-35-8
94 Chlorphenoxamine (INN) 77-38-3
95 2-[2-(4-Chlorophenyl)-2-phenylacetyl]indan 1,3-dione (chlorophacinone - ISO) 201-235-3 79-93-6
96 Chloroethane 200-830-5 75-00-3
97 Chromium; chromic acid and its salts 231-157-5 7440-47-3
98 Claviceps purpurea Tul., its alkaloids and galenical preparations 283-885-8 84775-56-4
99 Conium maculatum L. (fruit, powder, galenical preparations) 285-527-6 8511-75-2
100 Glycyclamide (INN) 211-557-6 664-95-9
101 Cobalt benzenesulphonate 23384-69-2
102 Colchicine, its salts and derivatives 200-598-5 64-86-8
103 Colchicoside and its derivatives 207-513-0 477-29-2
104 Golchicum autumnale L. and its galenical preparations 283-623-2 84696-03-7
105 Convallatoxin 208-086-3 508-75-8
106 Anamirta cocculus L. (fruit) 204-716-6 124-87-8
107 Croton tiglium (oil) 80014-28-3
108 1-Butyl-3-(N-crotonoylsulphanilyl)urea
109 Curare and curarine 232-511-1;244-880-6 8063-06-7; 22260-42-0
110 Synthetic curarizants
111 Hydrogen cyanide and its salts 200-821-6 74-90-8
112 2-α-Cyclohexylbenzyl(N,N,N’,N’,-tetraethyl)trimethylenediamine (phenetamine)
113 Cyclomenol (INN) and its salts 227-002-6 5591-47-9
114 Sodium hexacyclonate (INN) 7009-49-6
115 Hexapropymate (INN) 206-618-9 358-52-1
116 Dextropropoxyphene (INN) 207-420-5 469-62-5
117 O,O’-Diacetyl-N-allyl-N-normorphine 2748-74-5
118 Pipazetate (INN) and its salts 218-508-8 2167-85-3
119 5-(αβ-Dibromophenethyl)-5-methylhydantoin 208-133-8 511-75-1
120 N,N’-Pentamethylenebis (trimethylammonium salts), e.g. pentamethonium bromide (INN) 208-771-7 541-20-8
121 N,N’[(Methylimino)diethylene]bis(ethyldimethylammonium) salts, e.g. azamethonium bromide (INN) 206-186-1 306-53-6
122 Cyclarbamate (INN) 227-302-7 5779-54-4
123 Clofenotane; DDT (ISO) 200-024-3 50-29-3
124 N,N’-Hexamethylenebis(trimethylammonium) salts, e.g. hexamethonium bromide (INN) 200-249-7 55-97-0
125 Dichloroethanes (ethylene chlorides) 203-458-1 107-06-2
126 Dichloroethylenes (acetylene chlorides) 25323-30-2
127 Lysergide (INN) and its salts 200-033-2 50-37-3
128 2-Diethylaminoethyl-3-hydroxy-4-phenylbenzoate and its salts
129 Cinchocaine (INN) and its salts 201-632-1 85-79-0
130 3-Diethylaminopropyl cinnamate 538-66-9
131 O,O’-Diethyl O-4-nitrophenyl phosphorothioate (parathion-ISO) 200-271-7 56-38-2
132 [Oxalylbis iminoethylene)]bis[(o-chlorobenzyl)diethylammonium salts], e.g. ambenomium chloride (INN) 204-107-5 115-79-7
133 Methyprylon (INN) and its salts 204-745-4 125-64-4
134 Digitaline and all heterosides of Digitalis purpurea L. 212-036-6 752-61-4
135 7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline(xanthinol) 2530-97-4
136 Dioxethedrin (INN) and its salts 207-849-8 497-75-6
137 Piprocurarium (INN) 222-627-0 3562-55-8
138 Propyphenazone (INN) 207-539-2 479-92-5
139 Tetrabenazine (INN) and its salts 200-383-6 58-46-8
140 Captodiame (INN) 207-629-1 486-17-9
141 Mefeclorazine (INN) and its salts 1243-33-0
142 Dimethylamine 204-697-4 124-40-3
143 1,1-Bis(dimethylaminomethyl)propyl benzoate (amydricaine, alypine) and its salts 213-512-6 963-07-5
144 Methapyrilene (INN) and its salts 202-099-8 91-80-5
145 Metamfepramone (INN) and its salts 239-384-1 15351-09-4
146 Amitriptyline (INN) and its salts 200-041-6 50-48-6
147 Metformin (INN) and its salts 211-517-8 657-24-9
148 Isosorbide dinitrate (INN) 201-740-9 87-33-2
149 Malononitrile 203-703-2 109-77-3
150 Succinonitrile 203-783-9 110-61-2
151 Dinitrophenol isomers
152 Inproquone (INN) 436-40-8
153 Dimevamide (INN) and its salts 200-479-8 60-46-8
154 Diphenylpyraline (INN) and its salts 205-686-7 147-20-6
155 Sulfinpyrazone (INN) 200-357-4 57-96-5
156 N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethyl-ammonium salts, e.g. isopropamide iodide (INN) 200-766-8 71-81-8
157 Benactyzine (INN) 206-123-8 302-40-9
158 Benzatropine (INN) and its salts 86-13-5
159 Cyclizine (INN) and its salts 201-445-5 82-92-8
160 5,5-Diphenyl-4-imidazolidone 221-851-6 3254-93-1
161 Probenecid (INN) 200-344-3 57-66-9
162 Disulfiram (INN); thiram (ISO) 202-607-8;205-286-2

97-77-8;

137-26-8

163 Emetine, its salts and derivatives 207-592-1 483-18-1
164 Ephedrine and its salts 206-080-5 299-42-3
165 Oxanamide (INN) and its derivatives 126-93-2
166 Eserine or physostigmine and its salts 200-332-8 57-47-6
167 Esters of 4-aminobenzoic acid, with the free amino group, with the exception of that given in Schedule 7, Part 2 202-303-5 94-09-7
168 Choline salts and their esters, e.g. choline chloride 200-655-4 67-48-1
169 Caramiphen (INN) and its salts 201-013-6 77-22-5
170 Diethyl 4-nitrophenyl phosphate 206-221-0 311-45-5
171 Metethoheptazine (INN) and its salts 509-84-2
172 Oxpheneridine (INN) and its salts 546-32-7
173 Ethoheptazine (INN) and its salts 201-007-3 77-15-6
174 Metheptazine (INN) and its salts 469-78-3
175 Methylphenidate (INN) and its salts 204-028-6 113-45-1
176 Doxylamine (INN) and its salts 207-414-2 469-21-6
177 Tolboxane (INN) 2430-46-8
178 4-Benzyloxyphenol and 4-ethoxyphenol 203-083-3; 210-748-1 103-16-2; 622-62-8
179 Parethoxycaine (INN) and its salts 205-246-4 136-46-9
180 Fenozolone (INN) 239-339-6 15302-16-6
181 Glutethimide (INN) and its salts 201-012-0 77-21-4
182 Ethylene oxide 200-849-9 75-21-8
183 Bemegride (INN) and its salts 200-588-0 64-65-3
184 Valnoctamide (INN) 224-033-7 4171-13-5
185 Haloperidol (INN) 200-155-6 52-86-8
186 Paramethasone (INN) 200-169-2 53-33-8
187 Fluanisone (INN) 216-038-8 1480-19-9
188 Trifluperidol (INN) 749-13-3
189 Fluoresone (INN) 220-889-0 2924-67-6
190 Fluorouracil (INN) 200-085-6 51-21-8
191 Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with the exception of those given in Schedule 4, Part 1 231-634-8 7664-39-3
192 Furfuryltrimethylammonium salts, e.g. furtrethonium iodide (INN) 208-789-5 541-64-0
193 Galantamine (INN) 357-70-0
194 Progestogens
195 1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO) 200-401-2 58-89-9
196 (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethano-naphthalene (endrin-ISO) 200-775-7 72-20-8
197 Hexachloroethane 200-666-4 67-72-1
198 (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethano-naphthalene (isodrin-ISO) 207-366-2 465-73-6
199 Hydrastine, hydrastinine and their salts 204-233-0; 229-533-9 118-08-1; 6592-85-4
200 Hydrazides and their salts 54-85-3
201 Hydrazine, its derivatives and their salts 206-114-9 302-01-2
202 Octamoxin (INN) and its salts 4684-87-1
203 Warfarin (INN) and its salts 201-377-6 81-81-2
204 Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl) acetate and salts of the acid 208-940-5 548-00-5
205 Methocarbamol (INN) 208-524-3 532-03-6
206 Propatylnitrate (INN) 220-866-5 2921-92-8
207 4,4’-Dihydroxy-3,3’-(3-methylthiopropylidene) dicoumarin
208 Fenadiazole (INN) 1008-65-7
209 Nitroxoline (INN) and its salts 223-662-4 4008-48-4
210 Hyoscyamine, its salts and derivatives 202-933-0 101-31-5
211 Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations) 283-265-7 84603-65-6
212 Pemoline (INN) and its salts 218-438-8 2152-34-3
213 Iodine 231-442-4 7553-56-2
214 Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide 208-772-2 541-22-0
215 Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) 232-385-8 8012-96-2
216 (2-Isopropylpent.4-enoyl)urea (apronalide) 208-443-3 528-92-7
217 α-Santonin [(3S,5aR,9bS)-3,3a,4,5,5a,9b-hexahydro-3,5a,9-trimethylnaphto [1,2-b] furan-2,8-dione] 207-560-7 481-06-1
218 Lobelia inflata L. and its galenical preparations 283-642-6 84696-23-1
219 Lobeline and its salts 202-012-3 90-69-7
220 Barbiturates
221 Mercury and its compounds, except those special cases included in Schedule 6, Part 1 231-106-7 7439-97-6
222 3,4,5-Trimethoxyphenethylamine and its salts 200-190-7 54-04-6
223 Metaldehyde 203-600-2 108-62-3
224 2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts 305-13-5
225 Coumetarol (INN) 224-455-1 4366-18-1
226 Dextromethorphan (INN) and its salts 204-752-2 125-71-3
227 2-Methylheptylamine and its salts 540-43-2
228 Isometheptene (INN) and its salts 207-959-6 503-01-5
229 Mecamylamine (INN) 200-476-1 60-40-2
230 Guaifenesin (INN) 202-222-5 93-14-1
231 Dicoumarol (INN) 200-632-9 66-76-2
232 Phenmetrazine (INN), its derivatives and salts 205-143-4 134-49-6
233 Thiamazole (INN) 200-482-4 60-56-0
234 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano [3,2-c]-[1] benzopyran-5-one (cyclocoumarol) 208-248-3 518-20-7
235 Carisoprodol (INN) 201-118-7 78-44-4
236 Meprobamate (INN) 200-337-5 57-53-4
237 Tefazoline (INN) and its salts 1082-56-0
238 Arecoline 200-565-5 63-75-2
239 Poldine metilsulfate (INN) 208-894-6 545-80-2
240 Hydroxyzine (INN) 200-693-1 68-88-2
241 2-Naphthol 205-182-7 135-19-3
242 1-and 2-Naphthylamines and their salts 205-138-7; 202-080-4 134-32-7; 91-59-8
243 3-(1-Naphthyl)-4-hydroxycoumarin 39923-41-6
244 Naphazoline (INN) and its salts 212-641-5 835-31-4
245 Neostigmine and its salts (e.g. neostigmine bromide (INN)) 204-054-8 114-80-7
246 Nicotine and its salts 200-193-3 54-11-5
247 Amyl nitrites 203-770-8 110-46-3
248 Inorganic nitrites, with the exception of sodium nitrite 14797-65-0
249 Nitrobenzene 202-716-0 98-95-3
250 Nitrocresols and their alkali metal salts 12167-20-3
251 Nitrofurantoin (INN) 200-646-5 67-20-9
252 Furazolidone (INN) 200-653-3 67-45-8
253 Propane-1,2,3-triyl trinitrate 200-240-8 55-63-0
254 Acenocoumarol (INN) 205-807-3 152-72-7
255 Alkali pentacyanonitrosylferrate (2-) 238-373-9 14402-89-2
256 Nitrostilbenes, their homologues and their derivatives 223-653-5 4003-94-5
257 Noradrenaline and its salts 200-096-6 51-41-2
258 Noscapine (INN) and its salts 204-899-2 128-62-1
259 Guanethidine and its salts 200-241-3 55-65-2
260 Oestrogens
261 Oleandrin 207-361-5 465-16-7
262 Chlortalidone (INN) 201-022-5 77-36-1
263 Pelletierine and its salts 220-673-6 2858-66-4
264 Pentachloroethane 200-925-1 76-01-7
265 Pentaerythrityl tetranitrate (INN) 201-084-3 78-11-5
266 Petrichloral (INN) 78-12-6
267 Octamylamine (INN) and its salts 207-947-0 502-59-0
268 Picric acid 201-865-9 88-89-1
269 Phenacemide (INN) 200-570-2 63-98-9
270 Difencloxazine (INN) 5617-26-5
271 2-Phenylindan-1,3-dione (phenindione) 201-454-4 83-12-5
272 Ethylphenacemide (INN) 201-998-2 90-49-3
273 Phenprocoumon (INN) 207-108-9 435-97-2
274 Fenyramidol (INN) 209-044-7 553-69-5
275 Triamterene (INN) and its salts 206-904-3 396-01-0
276 Tetraethyl pyrophosphate; TEPP (ISO) 203-495-3 107-49-3
277 Tritolyl phosphate 215-548-8 1330-78-5
278 Psilocybine (INN) 208-294-4 520-52-5
279 Phosphorus and metal phosphides 231-768-7 7723-14-0
280 Thalidomide (INN) and its salts 200-031-1 50-35-1
281 Physostigma venenosum Balf. 289-638-0 89958-15-6
282 Picrotoxin 204-716-6 124-87-8
283 Pilocarpine and its salts 202-128-4 92-13-7
284 α-Piperidin-2-yl benzyl acetate laevorotatory threoform (levophacetoperane) and its salts 24558-01-8
285 Pipradrol (INN) and its salts 207-394-5 467-60-7
286 Azacyclonol (INN) and its salts 204-092-5 115-46-8
287 Bietamiverine (INN) 207-538-7 479-81-2
288 Butopiprine (INN) and its salts 259-848-7 55837-15-5
289 Lead and its compounds 231-100-4 7439-92-1
290 Coniine 207-282-6 458-88-8
291 Prunus laurocerasus L. (‘cherry laurel water’) 289-689-9 89997-54-6
292 Metyrapone (INN) 200-206-2 54-36-4
293 Radioactive substances, as defined by Directive 96/29/Euratom(1) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation.
294 Juniperus sabina L. (leaves, essential oil and galenical preparations) 90046-04-1 289-971-1
295 Hyoscine, its salts and derivatives 200-090-3 51-34-3
296 Gold salts 231-165-9 7440-57-5
297 Selenium and its compounds with the exception of selenium disulphiele under the conditions set out under reference No 49 in Schedule 4, Part 1 231-957-4 7782-49-2
298 Solanum nigrum L. and its galenical preparations 284-555-6 84929-77-1
299 Sparteine and its salts 201-988-8 90-39-1
300 Glucocorticoids
301 Datura stramonium L. and its galenical preparations 283-627-4 84696-08-2
302 Strophantines, their aglucones and their respective derivatives 234-239-9 11005-63-3
303 Strophantus species and their galenical preparations
304 Strychnine and its salts 200-319-7 57-24-9
305 Strychnos species and their galenical preparations
306 Narcotics, natural and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs signed in New York on 30 March 1961
307 Sulphonamides (sulphanilamide and its derivatives…) and their salts obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts 200-563-4 63-74-1
308 Sultiame (INN) 200-511-0 61-56-3
309 Neodymium and its salts 231-109-3 7440-00-8
310 Thiotepa (INN) 200-135-7 52-24-4
311 Pilocarpus jaborandi Holmes and its galenical preparations 283-649-4 84696-42-4
312 Tellurium and its compounds 236-813-4 13494-80-9
313 Xylometazoline and its salts 208-390-6 526-36-3
314 Tetrachloroethylene 204-825-9 127-18-4
315 Carbon tetrachloride 200-262-8 56-23-5
316 Hexaethyl tetraphosphate 212-057-0 757-58-4
317 Thallium and its compounds 231-138-1 7440-28-0
318 Thevetia neriifolia Juss., glycoside extract 290-446-4 90147-54-9
319 Ethionamide (INN) 208-628-9 536-33-4
320 Phenothiazine (INN) and its compounds 202-196-5 92-84-2
321 Thiourea and its derivatives, with the exception of the one listed in Schedule 4, Part 1 200-543-5 62-56-6
322 Mephenesin (INN) and its esters 200-427-4 59-47-2
323 Vaccines, toxins or serums listed in the Annex to the second Council Directive of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (OJ No L 147, 9. 6. 1975, p. 13)(2)
324 Tranylcypromine (INN) and its salts 205-841-9 155-09-9
325 Trichloronitromethane (chloropicrine) 200-930-9 76-06-2
326 2,2,2-Tribromoethanol (tribromoethyl alcohol) 200-903-1 75-80-9
327 Trichiormethine (INN) and its salts 212-442-3 817-09-4
328 Tretamine (INN) 200-083-5 51-18-3
329 Gallamine triethiodide (INN) 200-605-1 65-29-2
330 Urginea scilla Stern. and its galenical preparations 283-520-2 84650-62-4
331 Veratrine, its salts and galenical preparations 200-758-4 71-62-5
332 Schoenocaulon olficinale Lind. (seeds and galenical preparations) 283-296-6 84604-18-2
333 Veratrum Spp. and their preparations 290-407-1 90131-91-2
334 Vinyl chloride monomer 200-831-0 75-01-4
335 Ergocalciferol (INN) and cholecalciferol (vitamins D2 and D3) 200-014-9; 200-673-2 50-14-6; 67-97-0
336 Salts of O-alkyldithiocarbonic acids
337 Yohimbine and its salts 205-672-0 146-48-5
338 Dimethyl sulfoxide (INN) 200-664-3 67-68-5
339 Diphenhydramine (INN) and its salts 200-396-7 58-73-1
340 4-tert-Butylphenol 202-679-0 98-54-4
341 4-tert-Butylpyrocatechol 202-653-9 98-29-3
342 Dihydrotachysterol 200-672-7 67-96-9
343 Dioxane 204-661-8 123-91-1
344 Morpholine and its salts 203-815-1 110-91-8
345 Pyretbrum album L. and its galenical preparations
346 2-[4-Methoxybenzyl-N-(2-pyridyl)amino]ethyldimethylamine maleate 200-422-7 59-33-6
347 Tripelennamine (INN) 202-100-1 91-81-6
348 Tetrachlorosalicylanilides 7426-07-5
349 Dichlorosalicylanilides 1147-98-4
350 Tetrabromosalicylanilides
351 Dibromosalicylanilides 246-310-1 2455-64-7
352 Bithionol (INN) 202-565-0 97-18-7
353 Thiuram monosulphides
354 Thiuram disulphides 504-90-5
355 Dimethylformamide 200-679-5 68-12-2
356 4-Phenylbut-3-en-2-one 204-555-1 122-57-6
357 Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol except for normal content in natural essences used 207-277-9 458-35-5
358

Furocoumarines (e.g. trioxysalan (INN), 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used.

In sun protection and in bronzing products, furocoumarines shall be below 0,0001%

X223-459-0; 206-066-9; 207-604-5 3902-71-4; 298-81-7; 484-20-8
359 Oil from the seeds of Laurus nobilis L. 283-272-5 84603-73-6
360

Safrole except for normal content in the natural essences used and provided the concentration does not exceed:

0[a8],01% in the finished product,

0,005% in products for dental and oral hygiene, and provided that Safrole is not present in toothpastes intended specifically for children

202-345-4 94-59-7
361 5,5’-Di-isopropyl-2,2’-dimethylbiphenyl-4,4’-diyl dihypoiodite 209-007-5 552-22-7
362 3’-Ethyl-5’,6’,7’,8’-tetrahydro-5’,5’,8’,8’-tetramethyl-2’-acetonaphthone or 7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphtalen 201-817-7 88-29-9
363 o-phenylenediamine and its salts 202-430-6 95-54-5
364 4-methyl-m-phenylenediamine and its salts. 202-453-1 95-80-7
365 Aristolochic acid and its salts; Aristolochia spp. and their preparations 202-499-6; 206-238-3 475-80-9; 313-67-7; 15918-62-4
366 Chloroform 200-663-8 67-66-3
367 2,3,7,8-Tetra chlorodibenzo-p-dioxin 217-122-7 1746-01-6
368 2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane) 212-579-9 828-00-2
369 Pyrithione sodium (INN) 223-296-5 3811-73-2
370 N-(Trichloromethylthio)-4-cyclohexene-1,2-dicarboximide (captan) 205-087-0 133-06-2
371 2,2’-Dihydroxy-3,3’,5,5’,6,6’-hexachlorodiphenylmethane (hexachlorophene) 200-733-8 70-30-4
372 6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide (minoxidil) and its salts 253-874-2 38304-91-5
373 3,4’,5-Tribromosalicylanilide 201-723-6 87-10-5
374 Phytolacca spp. and their preparations 65497-07-6; 60820-94-2
375 Tretinoin (retinoic acid and its salts) 206-129-0 302-79-4
376 1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole - CI 76050) and their salts 210-406-1 615-05-4
377 1-Methoxy-2,5-diaminobenzene (2,5-diaminoanisole) and their salts 226-161-9 5307-02-8
378 Colouring agent CI 12140 221-490-4 3118-97-6
379 Colouring agent CI 26105 201-635-8 85-83-6
380

Colouring agent CI 42555

Colouring agent CI 42555-1

Colouring agent C1 42555-2

208-953-6;

207-396-6

548-62-9;

467-63-0

381 Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN)) 238-849-6 14779-78-3
382 [Omitted]
383 2-Amino-4-nitrophenol 202-767-9 99-57-0
384 2-Amino-5-nitrophenol 204-503-8 121-88-0
385 11 α-Hydroxypregn-4-ene-3,20-dione and its esters 201-306-9 80-75-1
386 Colouring agent C.I. 42 640 216-901-9 1694-09-3
387 Colouring agent CI 13 065 209-608-2 587-98-4
388 Colouring agent CI 42 535 8004-87-3
389 Colouring agent CI 61 554 241-379-4 17354-14-2
390 Anti-androgens of steroidal structure
391 Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Schedule 4, Part 1, and the zirconium lakes, pigments or salts of the colouring agents listed in Schedule 5, Part 1, with reference number (2) 231-176-9 7440-67-7
392 [Omitted]
393 Acetonitrile 200-835-2 75-05-8
394 Tetrahydrozoline and its salts 201-522-3 84-22-0
395 Hydroxy-8-quinoline and its sulphate, except for the uses provided for in No 51 in Schedule 4, Part 1 205-711-1; 205-137-1 145-24-3; 134-31-6
396 Dithio-2,2-bispyridine-dioxide 1,1’ (additive with trihydrated magnesium sulphate) - (pyrithione disulphide + magnesium sulphate) 256-115-3 43143-11-9
397 Colouring agent CI 12075 and its lakes, pigments and salts 222-429-4 3468-63-1
398 Colouring agent CI 45170 and CI 45170:1 201-383-9; 208-096-8 81-88-9; 509-34-2
399 Lidocaine 205-302-8 137-58-6
400 1,2-epoxybutane 203-438-2 106-88-7
401 Colouring agent CI 15585 225-935-3; 218-248-5 5160-02-1; 2092-56-0
402 Strontium lactate 249-915-9 29870-99-3
403 Strontium nitrate 233-131-9 10042-76-9
404 Strontium polycarboxylate
405 Pramocaine 205-425-7 140-65-8
406 4-ethoxy-m-phenylenediamine and its salts 5862-77-1
407 2,4-diaminophenylethanol and its salts 14572-93-1
408 Catechol 204-427-5 120-80-9
409 Pyrogallol 201-762-9 87-66-1
410 Nitrosamines
411 Secondary alkyl- and alkanolamines and their salts
412 4-Amino-2-nitrophenol 204-316-1 119-34-6
413 2-Methyl-m-phenylenediamine 212-513-9 823-40-5
414 4-tert-Butyl-3-methoxy-2,6-dinitrotoluene (Musk Ambrette) 201-493-7 83-66-6
415 [Omitted]
416 Cells, tissues or products of human origin
417 3,3-Bis(4-hydroxyphenyl)phthalide (Phenolphthalein (INN)) 201-004-7 77-09-8
418 3-Imidazol-4-ylacrylic acid and its ethyl ester (urocanic acid) 203-258-4 104-98-3
419 Category 1 material and category 2 material as defined in Articles 4 and 5 respectively of Regulation (EC) No 1774/2002 of the European Parliament and of the Council and ingredients derived there from animal products(3) and (4)
420 Crude and refined coal tars 232-361-7 8007-45-2
421 1,1,3,3,5,-Pentamethyl-4,6-dinitroindane (moskene) 204-149-4 116-66-5
422 5-tert-Butyl-1,2,3-trimethyl-4,6-dinitrobenzene (musk tibetene). 205-651-6 145-39-1
423 Alanroot oil (Inula helenium) X 97676-35-2
424 Benzyl cyanide 205-410-5 140-29-4
425 Cyclamen alcohol 225-289-2 4756-19-8
426 Diethyl maleate 205-451-9 141-05-9
427 Dihydrocoumarine 204-354-9 119-84-6
428 2,4-Dihydroxy-3-methylbenzaldehyde 228-369-5 6248-20-0
429 3,7-Dimethyl-2-octen-1-ol (6,7-Dihydrogeraniol) 254-999-5 40607-48-5
430 4,6-Dimethyl-8-tert-butylcoumarin 241-827-9 17874-34-9
431 Dimethyl citraconate X 617-54-9
432 7,11-Dimethyl-4,6,10-dodecatrien-3-one 247-878-3 26651-96-7
433 6,10-Dimethyl-3,5,9-undecatrien-2-one 205-457-1 141-10-6
434 Diphenylamine 204-539-4 122-39-4
435 Ethyl acrylate 205-438-8 140-88-5
436 Fig leaf absolute (Ficus carica) X 68916-52-9
437 trans-2-Heptenal when used as a fragrance ingredient 242-608-0 18829-55-5
438 trans-2-Hexenal diethyl acetal when used as a fragrance ingredient 266-989-8 67746-30-9
439 trans-2-Hexenal dimethyl acetal when used as a fragrance ingredient 242-204-4 18318-83-7
440 Hydroabietyl alcohol when used as a fragrance ingredient 236-476-3 13393-93-6
441 6-Isopropyl-2-decahydronaphthalenol when used as a fragrance ingredient 251-841-7 34131-99-2
442 7-Methoxycoumarin when used as a fragrance ingredient 208-513-3 531-59-9
443 4-(4-Methoxyphenyl)-3-butene-2-one when used as a fragrance ingredient 213-404-9 943-88-4
444 1-(4-Methoxyphenyl)-1-penten-3-one when used as a fragrance ingredient 203-190-5 104-27-8
445 Methyl trans-2-butenoate when used as a fragrance ingredient 210-793-7 623-43-8
446 7-Methylcoumarin when used as a fragrance ingredient 219-499-3 2445-83-2
447 5-Methyl-2,3-hexanedione when used as a fragrance ingredient 237-241-8 13706-86-0
448 2-Pentylidenecyclohexanone when used as a fragrance ingredient 247-178-8 25677-40-1
449 3,6,10-Trimethyl-3,5,9-undecatrien-2-one when used as a fragrance ingredient 214-245-8 1117-41-5
450 Verbena oil (Lippia citriodora Kunth.) when used as a fragrance ingredient X 8024-12-2
451

Methyleugenol except for normal content in the natural essences used and provided that the concentration does not exceed:

(a) 0,01 % in fine fragrance

(b) 0,004 % in eau de toilette

(c) 0,002 % in fragrance cream

(d) 0,001 % in rinse-off products

(e) 0,0002 % in other leave-on products and oral hygiene products.

93-15-2
452 6-(2-Chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane 253-704-7 37894-46-5
453 Cobalt dichloride 231-589-4 7646-79-9
454 Cobalt sulphate 233-334-2 10124-43-3
455 Nickel monoxide 215-215-7 1313-99-1
456 Dinickel trioxide 215-217-8 1314-06-3
457 Nickel dioxide 234-823-3 12035-36-8
458 Trinickel disulphide 234-829-6 12035-72-2
459 Tetracarbonylnickel 236-669-2 13463-39-3
460 Nickel sulphide 240-841-2 16812-54-7
461 Potassium bromate 231-829-8 7758-01-2
462 Carbon monoxide 211-128-3 630-08-0
463 Buta-1,3-diene 203-450-8 106-99-0
464 Isobutane if it contains ≥ 0,1 % w/w Butadiene 200-857-2 75-28-5
465 Butane if it contains ≥ 0,1 % w/w Butadiene 203-448-7 106-97-8
466 Gases (petroleum), C3-4, if they contain > 0,1 % w/w Butadiene 268-629-5 68131-75-9
467 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber, if it contains > 0,1 % w/w Butadiene 269-617-2 68307-98-2
468 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabiliser, if it contains > 0,1 % w/w Butadiene 269-618-8 68307-99-3
469 Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene 269-619-3 68308-00-9
470 Tail gas (petroleum), cracked distillate hydrotreater stripper, if it contains > 0,1 % w/w Butadiene 269-620-9 68308-01-0
471 Tail gas (petroleum), gas oil catalytic cracking absorber, if it contains > 0,1 % w/w Butadiene 269-623-5 68308-03-2
472 Tail gas (petroleum), gas recovery plant, if it contains > 0,1 % w/w Butadiene 269-624-0 68308-04-3
473 Tail gas (petroleum), gas recovery plant deethaniser, if it contains > 0,1 % w/w Butadiene 269-625-6 68308-05-4
474 Tail gas (petroleum), hydrodesulfurised distillate and hydrodesulfurised naphtha fractionator, acid-free, if it contains > 0,1 % w/w Butadiene 269-626-1 68308-06-5
475 Tail gas (petroleum), hydrodesulfurised vacuum gas oil stripper, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene 269-627-7 68308-07-6
476 Tail gas (petroleum), isomerised naphtha fractionation stabiliser if it contains > 0,1 % w/w Butadiene 269-628-2 68308-08-7,
477 Tail gas (petroleum), light straight-run naphtha stabiliser, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene 269-629-8 68308-09-8
478 Tail gas (petroleum), straight-run distillate hydrodesulferised, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene 269-630-3 68308-10-1
479 Tail gas (petroleum), propane-propylene alkylation feed prep deethaniser, if it contains > 0,1 % w/w Butadiene 269-631-9 68308-11-2
480 Tail gas (petroleum), vacuum gas oil hydrodesulferised, hydrogen sulfidefree if it contains > 0,1 % w/w Butadiene 269-632-4 68308-12-3
481 Gases (petroleum), catalytic cracked overheads, if they contain > 0,1 % w/w Butadiene 270-071-2 68409-99-4
482 Alkanes, C1-2, if they contain > 0,1 % w/w Butadiene 270-651-5 68475-57-0
483 Alkanes, C2-3, if they contain > 0,1 % w/w Butadiene 270-652-0 68475-58-1
484 Alkanes, C3-4, if they contain > 0,1 % w/w Butadiene 270-651-5 68475-59-2
485 Alkanes, C4-5, if they contain > 0,1 % w/w Butadiene 270-654-1 68475-60-5
486 Fuel-gases, if they contain > 0,1 % w/w Butadiene 270-667-2 68476-26-6
487 Fuel gases, crude oil distillates, if they contain> 0,1 % w/w Butadiene 270-670-9 68476-29-9
488 Hydrocarbons, C3-4, if they contain > 0,1 % w/w Butadiene 270-681-9 68476-40-4
489 Hydrocarbons, C4-5, if they contain > 0,1 % w/w Butadiene 270-682-4 68476-42-6
490 Hydrocarbons, C2-4, C3-rich, if they contain > 0,1 % w/w Butadiene 270-689-2 68476-49-3
491 Petroleum gases, liquefied, if they contain > 0,1 % w/w Butadiene 270-704-2 68476-85-7
492 Petroleum gases, liquefied, sweetened, if they contain > 0,1 % w/w Butadiene 270-705-8 68476-86-8
493 Gases (petroleum), C3-4, isobutane-rich, if they contain > 0,1 % w/w Butadiene 270-724-1 68477-33-8
494 Distillates (petroleum), C3-6, piperylene-rich, if they contain > 0,1 % w/w Butadiene 270-726-2 68477-35-0
495 Gases (petroleum), amine system feed, if they contain > 0,1 % w/w Butadiene 270-746-1 68477-65-6
496 Gases (petroleum), benzene unit hydrodesulferised off, if they contain > 0,1 % w/w Butadiene 270-747-7 68477-66-7
497 Gases (petroleum), benzene unit recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-748-2 68477-67-8
498 Gases (petroleum), blend oil, hydrogen-nitrogen-rich, if they contain > 0,1 % w/w Butadiene 270-749-8 68477-68-9
499 Gases (petroleum), butane splitter overheads, if they contain > 0,1 % w/w Butadiene 270-750-3 68477-69-0
500 Gases (petroleum), C2-3, if they contain > 0,1 % w/w Butadiene 270-751-9 68477-70-3
501

Gases (petroleum), catalytic-cracked gas oil depropaniser bottoms, C4-rich

acid-free, if they contain > 0,1 % w/w Butadiene

270-752-4 68477-71-4
502 Gases (petroleum), catalytic-cracked naphtha debutaniser bottoms, C3-5-rich, if they contain > 0,1 % w/w Butadiene 270-754-5 68477-72-5
503 Gases (petroleum), catalytic cracked naphtha depropaniser overhead, C3-rich acid-free, if they contain > 0,1 % w/w Butadiene 270-755-0 68477-73-6
504 Gases (petroleum), catalytic cracker, if they contain > 0,1 % w/w Butadiene 270-756-6 68477-74-7
505 Gases (petroleum), catalytic cracker, C1-5-rich, if they contain > 0,1 % w/w Butadiene 270-757-1 68477-75-8
506 Gases (petroleum), catalytic polymd. naphtha stabiliser overhead, C2-4-rich, if they contain > 0,1 % w/w Butadiene 68477-76-9
507 Gases (petroleum), catalytic reformed naphtha stripper overheads, if they contain > 0,1 % w/w Butadiene 270-759-2 68477-77-0
508 Gases (petroleum), catalytic reformer, C1-4-rich, if they contain > 0,1 % w/w Butadiene 270-760-8 68477-79-2
509 Gases (petroleum), C6-8 catalytic reformer recycle, if they contain > 0,1 % w/w Butadiene 270-761-3 68477-80-5
510 Gases (petroleum), C6-8 catalytic reformer, if they contain > 0,1 % w/w Butadiene 270-762-9 68477-81-6
511 Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-763-4 68477-82-7
512 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed, if they contain > 0,1 % w/w Butadiene 270-765-5 68477-83-8
513 Gases (petroleum), C2-return stream, if they contain > 0,1 % w/w Butadiene 270-766-0 68477-84-9
514 Gases (petroleum), C4-rich, if they contain > 0,1 % w/w Butadiene 270-767-6 68477-85-0
515 Gases (petroleum), deethaniser overheads, if they contain > 0,1 % w/w Butadiene 270-768-1 68477-86-1
516 Gases (petroleum), deisobutaniser tower overheads, if they contain > 0,1 % w/w Butadiene 270-769-7 68477-87-2
517 Gases (petroleum), depropaniser dry, propene-rich, if they contain > 0,1 % w/w Butadiene 270-772-3 68477-90-7
518 Gases (petroleum), depropaniser overheads, if they contain > 0,1 % w/w Butadiene 270-773-9 68477-91-8
519 Gases (petroleum), dry sour, gas-concn.-unit-off, if they contain > 0,1 % w/w Butadiene 270-774-4 68477-92-9
520 Gases (petroleum), gas concn. reabsorber distn., if they contain > 0,1 % w/w Butadiene 270-776-5 68477-93-0
521 Gases (petroleum), gas recovery plant depropaniser overheads, if they contain > 0,1 % w/w Butadiene 270-777-0 68477-94-1
522 Gases (petroleum), Girbatol unit feed, if they contain > 0,1 % w/w Butadiene 270-778-6 68477-95-2
523 Gases (petroleum), hydrogen absorber off, if they contain > 0,1 % w/w Butadiene 270-779-1 68477-96-3
524 Gases (petroleum), hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-780-7 68477-97-4
525 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich, if they contain > 0,1 % w/w Butadiene 270-781-2 68477-98-5
526 Gases (petroleum), isomerised naphtha fractionator, C4-rich, hydrogen sulfide-free, if they contain > 0,1 % w/w Butadiene 270-782-8 68477-99-6
527 Gases (petroleum), recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-783-3 68478-00-2
528 Gases (petroleum), reformer make-up, hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-784-9 68478-01-3
529 Gases (petroleum), reforming hydrotreater, if they contain > 0,1 % w/w Butadiene 270-785-4 68478-02-4
530 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich, if they contain > 0,1 % w/w Butadiene 270-787-5 68478-03-5
531 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich, if they contain > 0,1 % w/w Butadiene 270-788-0 68478-04-6
532 Gases (petroleum), thermal cracking distn., if they contain > 0,1 % w/w Butadiene 270-789-6 68478-05-7
533 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum, if it contains > 0,1 % w/w Butadiene 270-802-5 68478-21-7
534 Tail gas (petroleum), catalytic cracked naphtha stabilisation absorber, if it contains > 0,1 % w/w Butadiene 270-803-0 68478-22-8
535 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulferised combined fractionater, if it contains > 0,1 % w/w Butadiene 270-804-6 68478-24-0
536 Tail gas (petroleum), catalytic cracker refractionation absorber, if it contains > 0,1 % w/w Butadiene 270-805-1 68478-25-1
537 Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser, if it contains > 0,1 % w/w Butadiene 270-806-7 68478-26-2
538 Tail gas (petroleum), catalytic reformed naphtha separator, if it contains > 0,1 % w/w Butadiene 270-807-2 68478-27-3
539 Tail gas (petroleum), catalytic reformed naphtha stabiliser, if it contains > 0,1 % w/w Butadiene 270-808-8 68478-28-4
540 Tail gas (petroleum), cracked distillate hydrotreater separator, if it contains > 0,1 % w/w Butadiene 270-809-3 68478-29-5
541 Tail gas (petroleum), hydrodesulfurised straight-run naphtha separator, if it contains > 0,1 % w/w Butadiene 270-810-9 68478-30-8
542 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich, if it contains > 0,1 % w/w Butadiene 270-813-5 68478-32-0
543 Tail gas (petroleum), saturate gas recovery plant, C1-2-rich, if it contains > 0,1 % w/w Butadiene 270-814-0 68478-33-1
544 Tail gas (petroleum), vacuum residues thermal cracker, if it contains > 0,1 % w/w Butadiene 270-815-6 68478-34-2
545 Hydrocarbons, C3-4-rich, petroleum distillate, if they contain > 0,1 % w/w Butadiene 270-990-9 68512-91-4
546 Gases (petroleum), catalytic reformed straight-run naphtha stabiliser overheads, if they contain > 0,1 % w/w Butadiene 270-999-8 68513-14-4,
547 Gases (petroleum), full-range straight-run naphtha dehexaniser off, if they contain > 0,1 % w/w Butadiene 271-000-8 68513-15-5
548 Gases (petroleum), hydrocracking depropaniser off, hydrocarbon-rich, if they contain > 0,1 % w/w Butadiene 271-001-3 68513-16-6
549 Gases (petroleum), light straight-run naphtha stabiliser off, if they contain > 0,1 % w/w Butadiene 271-002-9 68513-17-7
550 Gases (petroleum), reformer effluent high-pressure flash drum off, if they contain > 0,1 % w/w Butadiene 271-003-4 68513-18-8
551 Gases (petroleum), reformer effluent low-pressure flash drum off, if they contain > 0,1 % w/w Butadiene 271-005-5 68513-19-9
552 Residues (petroleum), alkylation splitter, C4-rich, if they contain > 0,1 % w/w Butadiene 271-010-2 68513-66-6
553 Hydrocarbons, C1-4, if they contain > 0,1 % w/w Butadiene 271-032-2 68514-31-8
554 Hydrocarbons, C1-4, sweetened, if they contain > 0,1 % w/w Butadiene 271-038-5 68514-36-3
555 Gases (petroleum), oil refinery gas distn. off, if they contain > 0,1 % w/w Butadiene 271-258-1 68527-15-1
556 Hydrocarbons, C1-3, if they contain > 0,1 % w/w Butadiene 271-259-7 68527-16-2
557 Hydrocarbons, C1-4, debutanizer fraction, if they contain > 0,1 % w/w Butadiene 271-261-8 68527-19-5
558 Gases (petroleum), benzene unit hydrotreater depentaniser overheads, if they contain > 0,1 % w/w Butadiene 271-623-5 68602-82-4
559 Gases (petroleum), C1-5, wet, if they contain > 0,1 % w/w Butadiene 271-624-0 68602-83-5
560 Gases (petroleum), secondary absorber off, fluidised catalytic cracker overheads fractionator, if they contain > 0,1 % w/w Butadiene 271-625-6 68602-84-6
561 Hydrocarbons, C2-4, if they contain > 0,1 % w/w Butadiene 271-734-9 68606-25-7
562 Hydrocarbons, C3, if they contain > 0,1 % w/w Butadiene 271-735-4 68606-26-8
563 Gases (petroleum), alkylation feed, if they contain > 0,1 % w/w Butadiene 271-737-5 68606-27-9
564 Gases (petroleum), depropaniser bottoms fractionation off, if they contain > 0, % w/w Butadiene 271-742-2 68606-34-8
565 Petroleum products, refinery gases, if they contain > 0,1 % w/w Butadiene 271-750-6 68607-11-4
566 Gases (petroleum), hydrocracking low-pressure separator, if they contain > 0,1 % w/w Butadiene 272-182-1 68783-06-2
567 Gases (petroleum), refinery blend, if they contain > 0,1 % w/w Butadiene 272-183-7 68783-07-3
568 Gases (petroleum), catalytic cracking, if they contain > 0,1 % w/w Butadiene 272-203-4 68783-64-2
569 Gases (petroleum), C2-4, sweetened, if they contain > 0,1 % w/w Butadiene 272-205-5 68783-65-3
570 Gases (petroleum), refinery, if they contain > 0,1 % w/w Butadiene 272-338-9 68814-67-5
571 Gases (petroleum), platformer products separator off, if they contain > 0,1 % w/w Butadiene 272-343-6 68814-90-4
572 Gases (petroleum), hydrotreated sour kerosine depentaniser stabiliser off, if they contain > 0,1 % w/w Butadiene 272-775-5 68911-58-0
573 Gases (petroleum), hydrotreated sour kerosine flash drum, if they contain > 0,1 % w/w Butadiene 272-776-0 68911-59-1
574 Gases (petroleum), crude oil fractionation off, if they contain > 0,1 % w/w Butadiene 272-871-7 68918-99-0
575 Gases (petroleum), dehexaniser off, if they contain > 0,1 % w/w Butadiene 272-872-2 68919-00-6
576 Gases (petroleum), distillate unifiner desulfurisation tripper off, if they contain > 0,1 % w/w Butadiene 272-873-8 68919-01-7
577 Gases (petroleum), fluidised catalytic cracker fractionation off if they contain > 0,1 % w/w Butadiene 272-874-3 68919-02-8
578 Gases (petroleum), fluidised catalytic cracker scrubbing secondary absorber off, if they contain > 0,1 % w/w Butadiene 272-875-9 68919-03-9
579 Gases (petroleum), heavy distillate hydrotreater desulfurisation stripper off, if they contain > 0,1 % w/w Butadiene 272-876-4 68919-04-0
580 Gases (petroleum), light straight run gasoline fractionation stabiliser off, if they contain > 0,1 % w/w Butadiene 272-878-5 68919-05-1
581 Gases (petroleum), naphtha unifiner desulfurisation stripper off, if they contain > 0,1 % w/w Butadiene 272-879-0 68919-06-2
582 Gases (petroleum), platformer stabiliser off, light ends fractionation, if they contain > 0,1 % w/w Butadiene 272-880-6 68919-07-3
583 Gases (petroleum), preflash tower off, crude distn., if they contain > 0,1 % w/w Butadiene 272-881-1 68919-08-4
584 Gases (petroleum), straight-run naphtha catalytic reforming off, if they contain > 0,1 % w/w Butadiene 272-882-7 68919-09-5
585 Gases (petroleum), straight-run stabiliser off, if they contain > 0,1 % w/w Butadiene 272-883-2 68919-10-8
586 Gases (petroleum), tar stripper off, if they contain > 0,1 % w/w Butadiene 272-884-8 68919-11-9
587 Gases (petroleum), unifiner stripper off, if they contain > 0,1 % w/w Butadiene 272-885-3 68919-12-0
588 Gases (petroleum), fluidised catalytic cracker splitter overheads, if they contain > 0,1 % w/w Butadiene 272-893-7 68919-20-0
589 Gases (petroleum), catalytic cracked naphtha debutanizer, if they contain > 0,1 % w/w Butadiene 273-169-3 68952-76-1
590 Tail gas (petroleum), catalytic cracked distillate and naphtha stabiliser, if it contains > 0,1 % w/w Butadiene 273-170-9 68952-77-2
591 Tail gas (petroleum), catalytic hydrodesulfurised naphtha separator, if it contains > 0,1 % w/w Butadiene 273-173-5 68952-79-4
592 Tail gas (petroleum), straight-run naphtha hydrodesulferised, if it contains > 0,1 % w/w Butadiene 273-174-0 68952-80-7
593 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber, if it contains > 0,1 % w/w Butadiene 273-175-6 68952-81-8
594 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabiliser, petroleum coking, if it contains > 0,1 % w/w Butadiene 273-176-1 68952-82-9
595 Gases (petroleum), light steam-cracked, butadiene conc., if they contain > 0,1 % w/w Butadiene 273-265-5 68955-28-2
596 Gases (petroleum), sponge absorber off, fluidised catalytic cracker and gas oil desulfuriser overhead fractionation, if they contain > 0,1 % w/w Butadiene 273-269-7 68955-33-9
597 Gases (petroleum), straight-run naphtha catalytic reformer stabiliser overhead , if they contain > 0,1 % w/w Butadiene 273-270-2 68955-34-0
598 Gases (petroleum), crude distn. and catalytic cracking, if they contain > 0,1 % w/w Butadiene 273-563-5 68989-88-8
599 Hydrocarbons, C4, if they contain > 0,1 % w/w Butadiene 289-339-5 87741-01-3
600 Alkanes, C1-4, C3-rich, if they contain > 0,1 % w/w Butadiene 292-456-4 90622-55-2
601 Gases (petroleum), gas oil diethanolamine scrubber off, if they contain > 0,1 % w/w Butadiene 295-397-2 92045-15-3
602 Gases (petroleum), gas oil hydrodesulfurisation effluent, if they contain > 0,1 % w/w Butadiene 295-398-8 92045-16-4
603 Gases (petroleum), gas oil hydrodesulfurisation purge, if they contain > 0,1 % w/w Butadiene 295-399-3 92045-17-5
604 Gases (petroleum), hydrogenator effluent flash drum off, if they contain > 0,1 % w/w Butadiene 295-400-7 92045-18-6
605 Gases (petroleum), naphtha steam cracking high-pressure residual, if they contain > 0,1 % w/w Butadiene 295-401-2 92045-19-7
606 Gases (petroleum), residue vis breaking off, if they contain > 0,1 % w/w Butadiene 295-402-8 92045-20-0
607 Gases (petroleum), steam-cracker C3-rich, if they contain > 0,1 % w/w Butadiene 295-404-9 92045-22-2
608 Hydrocarbons, C4, steam-cracker distillate, if they contain > 0,1 % w/w Butadiene 295-405-4 92045-23-3
609 Petroleum gases, liquefied, sweetened, C4 fraction, if they contain > 0,1 % w/w Butadiene 295-463-0 92045-80-2
610 Hydrocarbons, C4, 1,3-butadiene- and isobutene-free, if they contain > 0,1 % w/w Butadiene 306-004-1 95465-89-7
611 Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free, if they contain > 0,1 % w/w Butadiene 307-769-4 97722-19-5
612 Benzo[def]chrysene (benzo[a]pyrene) 200-028-5 50-32-8
613 Pitch, coal tar-petroleum, if it contains > 0,005 % w/w benzo[a]pyrene 269-109-0 68187-57-5
614 Distillates (coal-petroleum), condensed-ring arom., if they contain > 0,005 % w/w benzo[a]pyrene 269-159-3 68188-48-7
615 [Omitted]
616 [Omitted]
617 Creosote oil, acenaphthene fraction, acenaphthene-free if it contains > 0,005 % w/w benzo[a]pyrene 292-606-9 90640-85-0,
618 Pitch, coal tar, low-temp., if it contains > 0,005 % w/w benzo[a]pyrene 292-651-4 90669-57-1
619 Pitch, coal tar, low-temp., heat-treated, if it contains > 0,005 % w/w benzo[a]pyrene 292-653-5 90669-58-2
620 Pitch, coal tar, low-temp., oxidised, if it contains > 0,005 % w/w benzo[a]pyrene 292-654-0 90669-59-3
621 Extract residues (coal), brown, if they contain > 0,005 % w/w benzo[a]pyrene 294-285-0 91697-23-3
622 Paraffin waxes (coal), brown-coal high-temp. tar, if they contain > 0,005 % w/w benzo[a]pyrene 295-454-1 92045-71-1
623 Paraffin waxes (coal), brown-coal high-temp. tar, hydrotreated, if they contain > 0,005 % w/w benzo[a]pyrene 295-454-1 92045-72-2
624 Waste solids, coal-tar pitch coking, if they contain > 0,005 % w/w benzo[a]pyrene 295-549-8 92062-34-5
625 Pitch, coal tar, high-temp., secondary, if it contains > 0,005 % w/w benzo[a]pyrene 302-650-3 94114-13-3
626 Residues (coal), liq. solvent extn., if they contain > 0,005 % w/w benzo[a]pyrene 302-681-2 94114-46-2
627 Coal liquids, liq. solvent extn. soln., if they contain > 0,005 % w/w benzo[a]pyrene 302-682-8 94114-47-3
628 Coal liquids, liq. solvent extn., if they contain > 0,005 % w/w benzo[a]pyrene 302-683-3 94114-48-4
629 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated if they contain > 0,005 % w/w benzo[a]pyrene 308-296-6 97926-76-6
630 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated, if they contain > 0,005 % w/w benzo[a]pyrene 308-297-1 97926-77-7
631 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated, if they contain > 0,005 % w/w benzo[a]pyrene 308-298-7 97926-78-8
632 Absorption oils, bicyclo arom. and heterocylic hydrocarbon fraction, if they contain > 0,005 % w/w benzo[a]pyrene 309-851-5 101316-45-4
633 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene polypropylene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene 309-956-6 101794-74-5
634 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene 309-957-1 101794-75-6
635 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene 309-958-7 101794-76-7
636 Pitch, coal tar, high-temp., heat-treated, if it contains > 0,005 % w/w benzo[a]pyrene 310-162-7 121575-60-8
637 Dibenz[a,h]anthracene 200-181-8 53-70-3
638 Benz[a]anthracene 200-280-6 56-55-3
639 Benzo[e]pyrene 205-892-7 192-97-2
640 Benzo[j]fluoranthene 205-910-3 205-82-3
641 Benz(e)acephenanthrylene 205-911-9 205-99-2
642 Benzo(k)fluoranthene 205-916-6 207-08-9
643 Chrysene 205-923-4 218-01-9
644 2-Bromopropane 200-855-1 75-26-3
645 Trichloroethylene 201-167-4 79-01-6
646 1,2-Dibromo-3-chloropropane 202-479-3 96-12-8
647 2,3-Dibromopropan-1-ol 202-480-9 96-13-9
648 1,3-Dichloropropan-2-ol 202-491-9 96-23-1
649 α,α,α-Trichlorotoluene 202-634-5 98-07-7
650 α-Chlorotoluene 202-853-6 100-44-7
651 1,2-Dibromoethane 203-444-5 106-93-4
652 Hexachlorobenzene 204-273-9 118-74-1
653 Bromoethylene 209-800-6 593-60-2
654 1,4-Dichlorobut-2-ene 212-121-8 764-41-0
655 Methyloxirane 200-879-2 75-56-9
656 (Epoxyethyl)benzene 202-476-7 96-09-3
657 1-Chloro-2,3-epoxypropane 203-439-8 106-89-8
658 R-1-Chloro-2,3-epoxypropane 424-280-2 51594-55-9
659 1,2-Epoxy-3-phenoxypropane 204-557-2 122-60-1
660 2,3-Epoxypropan-1-ol 209-128-3 556-52-5
661 R-2,3-Epoxy-1-propanol 404-660-4 57044-25-4
662 2,2′-Bioxirane 215-979-1 1464-53-5
663 (2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[1H-1,2,4-triazol-1-yl)methyl]oxirane epoxiconazole